KREMEN2 and neoplasm: Subgroup analysis was performed based on the age, sex, tumour site, TNM stage, CEA, tumour size, differentiation, peripheral nerve invasion, lymphovascular invasion, and MMR for determining the association of Kremen2 protein expression and clinicopathological parameters.